Allulose Modulates Oral Microbiota and Biofilm Formation via Its Low Cariogenic Potential

Formulators know allulose for its sweetness and functional profile. The oral health side is less familiar. It deserves attention. A 2025 study in Frontiers in Cellular and Infection Microbiology placed allulose next to sucrose, glucose, fructose, xylitol, and erythritol. The result is clear: allulose doesn't feed oral biofilms the way sugar does.

Why oral biofilms matter

Tooth decay starts at the biofilm level. Streptococcus mutans and other bacteria colonize teeth, ferment carbohydrates, and pump out acid. They also build extracellular polysaccharides that make plaque stickier and more resilient. Sucrose is the reference point. It drives bacterial growth, acid output, and matrix formation. The researchers wanted to know whether allulose behaves like a sugar or like a non-fermentable sweetener.

What the researchers did

The team used an oral biofilm model to compare allulose with sucrose, glucose, fructose, xylitol, and erythritol. They measured bacterial growth, acid output, biofilm architecture, microbial diversity, and expression of cariogenic genes in S. mutans.

What the study found

Allulose supported lower bacterial growth and acid production than sucrose, glucose, or fructose. Its profile matched xylitol and erythritol. That was true at the community level and at the gene level.

Sucrose produced thick biofilms with dense extracellular polysaccharide-encased microcolonies and dome-shaped structures. Allulose had no such architecture. Biofilms formed under allulose kept higher microbial diversity instead of letting S. mutans dominate.

Acid output told the same story. Compared with sucrose, allulose lowered acid production by 99%.

The genetic data strengthened the finding. S. mutans exposed to allulose significantly downregulated gtfD, ldh, and atpD. Those genes matter: gtfD supports glucan production, ldh drives lactic acid formation, and atpD helps the bacteria tolerate acid stress. When all three move in the same direction, allulose disrupts the usual cariogenic cascade.

Condition	Growth and acid output	Biofilm structure	Virulence gene activity
Sucrose	High growth and acid production	Dense EPS-encased microcolonies; dome-shaped structures	Reference for high cariogenic activity
Allulose	Lower growth and acid; similar to xylitol and erythritol	No dense EPS-encased microcolonies or dome structures; higher microbial diversity	gtfD, ldh, and atpD significantly downregulated

What this means for formulators

Sugar alcohols have carried the oral-care sweetener category. Xylitol and erythritol have strong dental credentials. Allulose is not a polyol, but this study shows it can perform like one in an in vitro oral biofilm model. That changes the sweetener conversation.

For product developers, allulose becomes a candidate for formulations designed around less aggressive plaque behavior. That includes confections, chewing gum, lozenges, and beverages. The data won't support a clinical claim on its own, but it gives R&D teams a reason to put allulose into side-by-side trials with erythritol or xylitol.

For ingredient buyers, the question is less about replacing one sweetener and more about expanding options. Allulose now comes with a defined oral microbiology profile. That adds value in customer conversations, especially for buyers supplying brands that target dental health. Regulatory claim rules still matter. Different markets have different standards for "does not promote tooth decay." The study is not a regulatory submission.

Frequently asked questions

Does this mean allulose is non-cariogenic?

It means allulose showed low cariogenic potential in this experimental model. Clinical caries endpoints weren't measured. If you need a label claim, compare the study against the claim requirements in your target market and build a complete dossier.

How does allulose compare with xylitol and erythritol?

In this study, allulose matched xylitol and erythritol for low bacterial growth and acid output relative to sucrose. But each sweetener offers different sweetness, bulk, solubility, and processing behavior. The oral data doesn't erase those formulation differences.

Should I switch from erythritol to allulose?

Not based on this paper alone. The oral biofilm results are encouraging, but a switch needs sensory testing, cost modeling, and shelf-life validation. Use the study as a starting point, not a finish line.

The dental health story of allulose keeps getting more concrete. This paper shows that allulose doesn't just sweeten—it changes how oral biofilms form and function. For anyone evaluating sweetener systems, that is a compelling reason to look closer.